Entry Detail



General Information

Database ID:exR0000385
RNA Name:AGPS
RNA Type:mRNA
Chromosome:chr2
Starnd:+
Coordinate:
Start Site(bp):177392757End Site(bp):177559299
External Links:ENSG00000018510



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
C2orf81
chr2
74414176
74421591
-
ZDHHC8
chr22
20129456
20148007
+
HES1
chr3
194136148
194138732
+
AP2M1
chr3
184174689
184184091
+
NDUFB11
chrX
47142216
47145504
-
RPS3A
chr4
151099624
151104642
+
NUDT15
chr13
48037726
48047221
+
HMGCR
chr5
75336329
75362101
+
OXA1L
chr14
22766522
22773042
+
RPL27A
chr11
8682788
8714759
+
RAB7A
chr3
128726183
128814798
+
RSRC2
chr12
122503454
122527000
-
CDCA7
chr2
173354820
173368997
+
DMWD
chr19
45782947
45792845
-
NCOR2
chr12
124324415
124567589
-
PSMC6
chr14
52707178
52728590
+
ATF4
chr22
39519695
39522685
+
EIF4G3
chr1
20806292
21176888
-
RPS24
chr10
78033760
78056813
+
ANAPC4
chr4
25377213
25418498
+
KHSRP
chr19
6413348
6424794
-
PSMB7
chr9
124353465
124415444
-
TRAP1
chr16
3651639
3717553
-
NCAPD2
chr12
6493356
6531955
+
FEZF2
chr3
62369681
62374324
-
ENO1
chr1
8861000
8879190
-
GPR176
chr15
39799008
39920266
-
HSPA4
chr5
133052013
133106449
+
RPL12
chr9
127447674
127451406
-
PARP2
chr14
20343582
20357905
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AL022311.1
chr22
37876148
37895563
+
AC138932.3
chr16
14909887
14911345
-
AP005263.1
chr18
9102736
9254346
+
LINC00910
chr17
43338741
43389199
-
LINC01641
chr1
227393554
227431035
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.